September 30, 2020
Shionogi said on September 29 that the US FDA has granted approval for its novel antibiotic Fetroja (cefiderocol) for an additional indication of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP). The drug is newly indicated for the treatment...read more